Previously, we reported that administration of prolactin (PRL) during the early luteal phase in sows increases plasma progesterone concentrations. In the current study, we searched for the mechanisms by which PRL exerts this luteotrophic effect. The objectives of the study were (1) to examine the effect of PRL and/or low-density lipoproteins (LDL) on progesterone production by porcine luteal cells derived from early corpora lutea, and (2) to assess the ability of PRL to activate phosphoinositide-specific phospholipase C (PI-PLC) and protein kinase C (PKC) in these luteal cells. Ovaries with early corpora lutea (day 1-2 of the oestrous cycle) were obtained from the slaughterhouse. Progesterone production by dispersed luteal cells was measured after treatment with PRL, phorbol 12myristate 13-acetate or inhibitors of PKC in the presence or absence of LDL. LDL increased progesterone concentration in the incubation medium (304·5 vs 178·6 ng/ml in control, P<0·05). PRL augmented LDL-stimulated progesterone secretion by luteal cells (to 416 ng/ml, P<0·05), but PRL alone did not affect progesterone production (209·6 ng/ml, P>0·05). Staurosporine, a PKC inhibitor, inhibited progesterone secretion stimulated by the combined action of LDL and PRL; however, such inhibition was not demonstrated when cells were treated with the PKC inhibitor, H-7. PKC activation was assessed by measuring the specific association of [ 3 H]phorbol dibutyrate ( 3 H-PDBu) with luteal cells after treatment with PRL or ionomycin (a positive control). PRL and ionomycin increased 3 H-PDBu-specific binding in early luteal cells by 28 5·5% (within 5 min) and 70·2 19·3% (within 2 min) over control binding respectively (P<0·05). In addition, PRL did not augment the LDLstimulated progesterone production in PKC-deficient cells. In contrast with PKC, total inositol phosphate accumulation, as well as intracellular free calcium concentrations, were not affected by PRL in the current study. We conclude that PRL, in the presence of LDL, stimulates progesterone production by early corpora lutea in vitro.
Introduction
Prolactin (PRL), among its various functions, is regarded as the most important constituent of the luteotrophic complex in rodents and carnivores (Murphy & Rajkumar 1985) , but its significance in pigs has not been fully elucidated (Dusza & Tilton 1990) . In our previous in vivo study, administration of PRL in the early luteal phase elevated plasma concentrations of progesterone (Ciereszko & Dusza 1993) . In addition, we found that corpora lutea obtained from sows treated in vivo with PRL during the early luteal phase produce more progesterone in vitro than those from control sows (Dusza et al. 1993) . In vitro studies (Gregoraszczuk 1983 (Gregoraszczuk , 1991 revealed that, in the presence of calf serum, PRL stimulates progesterone secretion by porcine luteal cells derived from the early luteal phase (days 1-2 of the oestrous cycle). Results of experiments performed on rats and pregnant pigs suggest that PRL affects luteal processing of lipoproteins (Rajkumar et al. 1985a,b) . Thus PRL may be involved in the control of steroidogenesis during the early luteal phase of pigs. However, the physiological mechanisms responsible for these events are still unknown.
Because of the wide range of physiological functions ascribed to PRL, and the existence of distinct forms of the PRL receptors (Kelly et al. 1991 , Doppler 1993 , it is probable that more than one mechanism is involved in PRL signalling. Several intracellular pathways in different tissues have been recently postulated to transduce the signal for PRL. These include the phosphatidylinositol (PI) pathway (Rillema et al. 1988 , DeVito et al. 1993 , Doppler 1994 , Rao et al. 1995 , which encompasses phospholipase C (PLC), calcium ions and protein kinase C (PKC), the tyrosine kinase/Ras pathway (Clevenger & Medaglia 1994 , Clevenger et al. 1994 , Carey & Liberti 1995 , Erwin et al. 1995 and the JAK ( Janus tyrosine kinase)/STAT (signal transducers and activators) pathway (Campbell et al. 1994 , Doppler 1994 , Schindler 1995 , Dajee et al. 1996 , Watson & Burdon 1996 , Hennighausen et al. 1997 . Surprisingly, only a few studies have addressed the mechanism of PRL action in reproductive tissues. PKC/ calcium ions may be involved in PRL signalling in human endometrium (Kalbag et al. 1991) and porcine granulosa cells (Szafrañska et al. 1993) . The principal isoenzymes of PKC are found in porcine ovarian tissue. Levels of PKC increase 3-to 9-fold during the process of luteinization in pigs (DeManno et al. 1992 ). In the current study, we tested the hypothesis that PRL, in the presence of lowdensity lipoprotein (LDL), stimulates progesterone production by luteal cells harvested during days 1-2 of the porcine oestrous cycle. In addition, we examined the possible involvement of the PI pathway and PKC in this phenomenon.
Materials and Methods

Chemicals
Dr K Kochman, Institute of Animal Physiology and Nutrition, Jablonna, Poland purified the porcine PRL. The purification procedure was essentially that described by Li (1976) , but a purification step involving DEAEcellulose chromatography was introduced as described by Kochman & Kochman (1977) . This preparation of porcine PRL was free of porcine growth hormone, luteinizing hormone (LH) and follicle-stimulating hormone as tested by PAGE. Radiochemicals were purchased from New England Nuclear, Boston, MA, USA. Collagenase (Cls 4) was purchased from Worthington Biochemicals, Freehold, NJ, USA. AG 1-X3 ion-exchange resin was obtained from Bio-Rad Laboratories, Richmond, CA, USA. Fura-2 acetoxymethyl ester was obtained from Molecular Probes, Eugene, OR, USA. Medium 199 (M199) was purchased from Gibco, Grand Island, NY, USA. Ionomycin was purchased from Calbiochem, San Diego, CA, USA. Dr Gordon Niswender, Colorado State University, donated a specific and proven antibody against progesterone. All other chemicals were purchased from Sigma Chemical Co., St Louis, MO, USA.
LDL isolation
LDLs were isolated from porcine blood by ultracentrifugation with KBr using the method of Havel et al. (1955) as modified by Radding & Sternberg (1960) . The lipoproteins were then dialysed for 48 h against 0·15 M NaCl/ 0·3 mM EDTA, pH 7·4. Cholesterol content was quantified by the method of Wybenga et al. (1970) . Lipoproteins were stored at 4 C and used within 5 weeks of preparation.
Tissue preparation
Corpora lutea were collected from sows within 15 min of slaughter at a local abattoir. Ovaries bearing early corpora lutea (days 1-2 of the oestrous cycle) were identified by gross morphology (Akins & Morrissette 1968 ) and transported to the laboratory in M199 at 4 C. Corpora lutea were dissected from the ovarian stroma, decapsulated, and minced. Minced luteal tissue was dissociated by gentle mechanical agitation and enzymic digestion using collagenase (600 U/ml, 37 C). After dissociation, dispersed cells were washed with M199 and counted by haemocytometry. Viability was determined by trypan blue exclusion.
Experimental design
Experiment 1: effects of PRL and LDL on progesterone production by porcine early luteal tissue in vitro Luteal cells (100 000 cells/ml M199) were incubated for 8 h in a gyratory shaker bath at 37 C under an atmosphere of 95% O 2 /5% CO 2 . Treatments were factorially arranged and included different concentrations of PRL (2, 20, 200, 2000 ng/ml; n=6 pigs) and porcine LDL (140 µg cholesterol/ml). The most effective dose of PRL (200 ng/ml) was tested three more times. As such, the 200 ng/ml dose of PRL was tested in corpora lutea from nine pigs. The concentration of LDL used for these experiments was established on the basis of the results of a preliminary study. After incubation, medium was collected and stored at 20 C. Progesterone levels were later quantified by RIA.
Experiment 2: effect of PRL on PLC activity in porcine early luteal tissue in vitro Hydrolysis of PI was monitored by quantifying the amount of inositol phosphates (IPs) liberated by early luteal cells (1 10 6 cells/ml; n=5 pigs) during a 30 min incubation at 37 C in medium (M199+10 mM LiCl) with or without PRL (200 ng). Before treatment, the PI within the cells was labelled by incubation with myo-[ 3 H]inositol (100 µCi/ml) for 3 h at 37 C. Labelled IPs were isolated and quantified by affinity chromatography on columns of AG 1-X8 resin followed by liquid-scintillation spectroscopy (Bone et al. 1984 , Houmard et al. 1992 . For details of the technique, see Houmard et al. (1992) . The technique has been used successfully in our laboratory to measure prostaglandin F 2 -induced increases in accumulation of inositol phosphates in incubations of primate luteal cells (Houmard et al. 1992 (Houmard et al. , 1994 .
Experiment 3: effect of PRL on intracellular calcium in steroidogenic cells from porcine early luteal tissue
Concentration of free intracellular calcium ([Ca 2+ ] i ) was measured using fura-2 fluorescence photometry of individual steroidogenic cells from porcine early corpora lutea. Before microscopy, luteal cells (400 000 cells/ml; n=4 pigs, seven or eight cells per animal) were preincubated in 1 ml F-10 medium with fura-2 acetoxymethyl ester (5 µM) at 37 C in a 95% O 2 /5% CO 2 atmosphere. Cells were then washed and incubated in fresh medium for 60 min to allow complete hydrolysis of the fura-2 ester. The ratio of emission (420-620 nm) of fura-2 at 348/380 nm excitation during a 5 min perfusion of the cells with F-10 in the presence and absence of PRL (200 ng/ml) was measured using a Zeiss IM microscope and 63 Plan Neofluar objective. Solutions were perfused in random order and each cell was used as its own control. For details of this technique, see Houmard et al. (1992) . We have used it successfully to measure increases in intracellular calcium ion concentration ([Ca 2+ ] i ) after treatment of primate (Houmard et al. 1992 (Houmard et al. , 1994 Experiment 4: effects of PRL on PKC activation in porcine early luteal tissue in vitro PKC activation by PRL was assessed in intact luteal cells by determining changes in the specific binding of [ 3 H]phorbol 12,13dibutyrate ( 3 H-PDBu). This assay is based on the propensity of PKC to translocate to the membrane upon activation and to associate readily with phorbol esters when in this active state. 3 H-PDBu was used at a concentration well below that necessary to activate PKC. Luteal cells (100 000 cells/600 µl; n=5 pigs) were preincubated for 30 min in buffer (140 mM NaCl, 6 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 15 mM HEPES and 5·6 mM glucose, pH 7·2, at 37 C) containing 16 nM 3 H-PDBu to allow equilibration of the labelled phorbol. Aliquots of cells were then added to treatment mixtures and incubated at 37 C for 1, 2, 3 and 5 min. Treatments were performed in duplicate and the mixtures included incubation buffer, PRL (200 ng/ml) and ionomycin (1 µM, a positive control). Non-specific binding was assessed at each time point using excess unlabelled PDBu (10 µM). After incubation, cell-associated 3 H-PDBu was isolated by vacuum filtration and quantified by liquid-scintillation spectroscopy. PKC activation was calculated as the percentage of control specific binding: [(d.p.m. treatment) (d.p.m. nonspecific binding)]/[(d.p.m. control) (d.p.m. non-specific binding)] 100%. This technique has been used successfully to measure PKC activation in phagocytic cells (Dougherty & Niedel 1986 , Walters et al. 1992 ), and we have previously used it to measure PKC activation in primate luteal cells (Ciereszko et al. 1995) .
Experiment 5: effects of PKC inhibitors on PRL+LDL-stimulated progesterone production by porcine early luteal tissue in vitro
Luteal cells (100 000 cells/ml M199, n=5 pigs) were incubated with treatment mixtures for 8 h at 37 C under an atmosphere of 95% O 2 /5% CO 2 . Treatment mixtures included PRL (200 ng/ ml)+LDL (140 µg cholesterol/ml), staurosporine (100 nM), H-7 (100 µM), staurosporine+PRL+LDL, and H-7+PRL+LDL. Staurosporine and H-7 are selective inhibitors of PKC. To determine if any effect of these inhibitors was due to interference with substrate utilization, we ran a separate experiment comparing progesterone production in the presence of LDL, with and without staurosporine or H-7 (n=5 pigs). The inhibitor concentrations used in these experiments were based on those used in other experiments (Bayat-Sarmadi & Houdebine 1993 , DeVito et al. 1993 . Medium was collected and stored at 20 C until quantification of progesterone by RIA.
Experiment 6: effect of an activator of PKC on progesterone production by porcine early luteal tissue in vitro
Luteal cells (100 000 cells/ml M199; n=7 pigs) were incubated for 4 h with increasing doses of phorbol 12-myristate 13-acetate (PMA; 0, 0·125, 0·25, 1·25, 2·5 and 12·5 ng/ml) at 37 C under an atmosphere of 95% O 2 /5% CO 2 . PMA is a potent activator of PKC. Cells were treated in the presence and absence of porcine LDL (140 µg cholesterol/ml). After incubation, medium was collected and stored at 20 C until quantification of progesterone by RIA.
Experiment 7: effect of PRL and LDL on progesterone production by PKC-deficient luteal cells PKCdeficient luteal cells (50 000 cells/ml M199; n=4 pigs) were produced by incubating cells for 12 h in the presence of 1 µM PMA. Such treatment specifically reduces PKC activity (Wiltbank et al. 1989 , Clement et al. 1997 . Control cells were incubated for 12 h with dimethyl sulphoxide, the solvent for PMA, or M199. Then all cells were extensively washed and incubated for 8 h at 37 C in M199 in the presence or absence of PRL (200 ng/ml) and/or LDL. After incubation, medium was collected and stored at 20 C until quantification of progesterone by RIA.
RIA of progesterone
RIA was used to measure concentrations of progesterone in samples of M199 incubated with dispersed luteal cells. The validation of this assay for use with primate luteal-conditioned medium has been reported previously ( Johnson et al. 1988) . In order to validate the assay for use with medium incubated with porcine corpora lutea, a standard curve with a slope of approximately 2·0 after a log/logit transformation was established using 2·5-500 pg standards. The standard curve (m= 1·95) was parallel to a curve prepared by the addition of 10, 20 and 40 µl (1:100 dilution) of porcine luteal incubate (m= 1·88). Cold recovery of progesterone from porcine luteal conditioned medium was 101·5 6·4%. Exogenous treatments did not interfere with the RIAs. Experimental samples were diluted 1:100 and run in duplicate at 10-50 µl per tube. Intra-assay and interassay coefficients of variation were 5·5 and 8·1%.
Data analysis
Analyses were performed using the Statistical Analysis System (SAS) or Statistica (StatSoft Inc., Tulsa, OK, USA). The effects of PRL or PMA on basal and LDL-stimulated progesterone production were analysed using ANOVA for randomized complete block designs. Individual animals represented blocks. Individual treatment means were compared using a Tukey test. The same method was used to analyse the effect of inhibitors of PKC on progesterone production in the presence of PRL and LDL and the effect of PRL on accumulation of labelled IPs. The effect of PRL and/or LDL on progesterone production by PKCdeficient cells was analysed using a two-way ANOVA for repeated measurements. Because of heterogeneity between animals in the temporal pattern of PKC activation (Experiment 4), data were standardized to the time of maximal activation. Student's t-test was used to compare the raw data (c.p.m. values) at the time of maximal stimulation in control and PRL-stimulated cells. The effect of ionomycin on PKC activation was also assessed in this way.
Results
LDL increased progesterone secretion by porcine luteal cells (days 1-2 of the oestrous cycle) during 8 h of incubation. This stimulation was significantly (P<0·05) augmented by PRL. The PRL dose-response study revealed that the most effective concentration of this hormone was 200 ng/ml ( Fig. 1; Experiment 1 ). Therefore this concentration was used in all subsequent experiments. PRL alone did not influence progesterone secretion. Thus PRL appears to enhance LDL-stimulated progesterone production by cells obtained from early porcine corpora lutea. Total accumulation of IPs in porcine luteal cells was not altered by treatment with 200 ng PRL ( Fig. 2; Experiment 2 ). In addition, none of the luteal cells examined from four separate animals (Experiment 3, n=4 pigs, seven or eight cells per animal) responded to PRL with an increase in [Ca 2+ ] i . Thus [Ca 2+ ] i does not appear to be a critical mediator of PRL action in the porcine corpus luteum during the early luteal phase. These data do not support the notion that PRL activates PI-PLC. PRL (200 ng) increased specific binding of 3 H-PDBU to luteal cells ( Fig. 3 ; Experiment 4) by 28·8 5·9% over control binding (P<0·05). Similarly, ionomycin (1 µM), used as a positive control, increased 3 H-PDBu specific binding to luteal cells (by 70·3 19·2%). These increases occurred within 5 min of PRL stimulation and within 2 min of ionomycin stimulation. This type of response is consistent with activation of PKC.
In the next experiment, the effect of inhibitors of PKC on progesterone secretion was studied ( Fig. 4 ; Experiment 5). Staurosporine (100 nM) and H-7 (100 µM) were incubated with luteal cells in the presence and absence of LDL and/or PRL. Neither of the inhibitors affected LDL-stimulated progesterone production (data not shown) but staurosporine suppressed the stimulatory effect of the combined action of LDL and PRL (P<0·05).
We also tested the hypothesis that PMA, a specific activator of PKC, could mimic the action of PRL ( Fig. 5 ; Experiment 6). Increasing doses of PMA (0, 0·125, 0·25, 1·25, 2·5, 12·5 ng/ml) were added to cells incubated with or without LDL (4 h, 37 C). LDL increased progesterone secretion above control levels (P<0·05). The intermediate doses of PMA tended to augment the LDL-stimulated progesterone secretion. In addition, the lower doses of PMA tended to increase basal progesterone secretion. Since the response to PMA does not exactly mimic the response to PRL, the mechanism of PRL action may involve more than simple activation of PKC.
Figure 1
Effect of 200 ng PRL on basal and LDL-stimulated progesterone production by porcine luteal cells (n=9 pigs). Data are presented as means. The S.E.M. from the model used to analyse the data was 31·4. The inset represents the effect of increasing concentrations of PRL on basal and LDL-stimulated progesterone production by porcine luteal cells (n=6 pigs). Data are presented as means. For these experiments, luteal cells (days 1-2 of the oestrous cycle; 100 000/ml) were incubated for 8 h at 37 C. Bars without common superscripts were significantly different (P<0·05).
Finally, we found that, although LDL stimulated progesterone production by PKC-deficient luteal cells (PMApretreated cells), PRL did not augment this stimulation ( Fig. 6; Experiment 7) . However, the luteotrophic effect of PRL was observed (P<0·05) in both M199-( Fig. 6 ) and dimethyl sulphoxide-pretreated cells (data not shown). These data strengthen the hypothesis that PKC is involved in PRL signalling in porcine luteal cells originating from the first days of the oestrous cycle.
Discussion
In this study, we present a defined in vitro system mimicking the stimulatory effects of PRL on progesterone production by early porcine corpora lutea seen in vivo (Ciereszko & Dusza 1993) . This in vitro model was used to measure changes in parameters of the PI pathway after treatment of early luteal tissue with PRL. These experiments represent the first investigation into the role of the PI pathway during PRL action in the porcine corpus luteum.
PRL significantly stimulated progesterone secretion by porcine luteal cells derived from the early luteal phase of the oestrous cycle (days 1-2), but this effect required the presence of substrate in the form of LDL. This is in agreement with the studies of Gregoraszczuk (1983 Gregoraszczuk ( , 1991 , who reported the luteotrophic effect of PRL on porcine early corpora lutea in vitro in the presence of calf serum. Studies performed on granulosa cells (Rajkumar et al. 1988a) , luteinized granulosa cells (Rajkumar et al. 1988b ) and luteal tissue derived from pregnant animals ( Rajkumar et al. 1985b ) revealed that PRL affects binding and processing of lipoproteins in sows. This effect seems to be dependent upon pre-exposure to LH or human choriogonadotrophin in granulosa cell cultures (Chedrese et al. 1988 ). Moreover, we demonstrated recently that corpora lutea obtained from sows treated in vivo with PRL during the early luteal phase (i.e. after the preovulatory surge of LH) produce more progesterone than those obtained from control sows (Dusza et al. 1993) . Similarly, in the present study, the tissue had already been exposed to high concentrations of LH in vivo, probably rendering it responsive to PRL. Thus the luteotrophic effect of PRL seems to be exerted on early corpora lutea by enhancing the availability of substrate for ovarian steroidogenesis.
Ideas on the signal-transduction pathways involved in the intracellular mechanism of PRL action in gonadal cells remain speculative. A number of studies suggest the involvement of the PI pathway in PRL action in a variety of tissues including cultured mammary tissues, Nb2 node lymphoma cells, hypothalamic slices and astrocytes (Rillema et al. 1988 , DeVito et al. 1993 , Doppler 1994 , Rao et al. 1995 . Activation of this pathway initiates the hydrolysis of phosphatidylinositol 4,5-bisphosphate to inositol trisphosphate and diacylglycerol. Diacylglycerol activates PKC, and inositol trisphosphate stimulates release of calcium from intracellular stores. Such events are important in the mediation of a number of physiological responses triggered by many hormones, neurotransmitters and growth factors (Nishizuka 1992 , Exton 1994 , Liu 1996 .
Figure 4
Effects of staurosporine (STS) and H-7 on basal and stimulated progesterone production. Luteal cells (100 000/ml, n=5 pigs) were incubated at 37 C for 8 h with PRL (200 ng/ml) and LDL (140 µg cholesterol/ml) in the presence or absence of STS (100nM) or H-7 (100 µM). Data are presented as means. The S.E.M. from the model used to analyse the data is indicated. Bars without common superscripts are significantly different (P<0·05).
Figure 5
Effect of PMA on basal and LDL-stimulated progesterone production by porcine luteal cells obtained from early corpora lutea. Luteal cells (100 000/ml) were incubated at 37 C for 4 h with increasing doses of PMA (n=7 pigs). Data are presented as means. The S.E.M. from the model used to analyse the data is indicated.
Figure 6
Effect of LDL and PRL+LDL on progesterone production by luteal cells (days 1-2 of the oestrous cycle; 50 000 cells/ml; 8 h; 37 C; n=4 pigs) preincubated for 12 h with 1 µM PMA (PKC-deficient cells) or with M199. Data are presented as means S.E. Bars without common superscripts are significantly different (P<0·05).
In this study we examined several elements of the PI pathway that might be involved in the mechanism of PRL action in the luteal tissue of pigs. We studied the effect of PRL on [Ca 2+ ] i in luteal cells, as well as IP accumulation and 3 H-PDBu binding (PKC activation) by luteal cells. These events might lead to changes in processing of LDLs and consequently to the increase in steroidogenesis induced by PRL. Our results showed a clear and marked activation of PKC after treatment with PRL in vitro. The failure of PRL to augment the stimulatory effect of LDL on progesterone production in PKC-deficient cells, the reduction of the luteotrophic effect of PRL+LDL by staurosporine and the tendency of the intermediate concentrations of PMA to increase progesterone production further support the hypothesis that PKC is involved in PRL signalling in early corpora lutea of pigs. However, we have no evidence to suggest that this activation of PKC is associated with phosphatidylinositol 4,5-bisphosphate hydrolysis or increases in [Ca 2+ ] i . It is unlikely that the lack of change in IP accumulation and [Ca 2+ ] i was due to a deficiency in our methods. The current methods have been used in numerous experiments in our laboratory to demonstrate accumulation of IP by primate luteal cells in response to prostaglandins (Houmard et al. 1992 (Houmard et al. , 1994 (Houmard et al. , 1996 . In addition, we have evidence that prostaglandins increase [Ca 2+ ] i in primate and porcine luteal cells (Houmard et al. 1992 (Houmard et al. , 1994 (Houmard et al. , 1996 A number of studies performed on mammary gland cells , Banerjee & Vonderhaar 1992 , Fan & Rillema 1993 , Nb 2 node lymphoma cells , Rao et al. 1995 ), astrocytes (DeVito et al. 1993 and hypothalamus (DeVito et al. 1991 ) demonstrated that PKC is an important component of signal-transduction pathways induced by PRL. PKC is a family of serine/ threonine protein kinases consisting of multiple isoforms different in their structure, substrate specificity and regulatory characteristics (Nishizuka 1992 , Liu 1996 . Heterogeneity of this enzyme comprises, for instance, the existence of isoforms that are either dependent or not on calcium (Nishizuka 1992 , Liu 1996 , Wilkinson & Hallam 1994 . Recent evidence (for reviews see Ogita et al. 1990 , Merrill & Schroeder 1993 , Liscovitch & Cantley 1994 suggests that PKC may be activated by several mechanisms other than PI hydrolysis. Novel PKCs (isoforms , and ) may be activated by the production of diacylglycerol alone via the action of phospholipase D or after phosphatidylcholine hydrolysis by PLC. The isoform of PKC has been shown to be present in porcine follicular and luteal tissue (DeManno et al. 1992 ). In addition, some PKC isoforms may be activated by free fatty acids such as arachidonic acid generated by phospholipase A 2 (Ciereszko et al. 1995 , Liu 1996 . The absence of any increase in [Ca 2+ ] i after treatment of luteal cells with PRL in the present study suggests that such calcium-independent mechanisms may be responsible for the observed PKC activation.
Staurosporine, an inhibitor of PKC that acts on the catalytic subunit of the enzyme, prevented the stimulatory effects of PRL+LDL on steroidogenesis. However, this effect was not duplicated by H-7, a similar PKC inhibitor. This may be due to a failure of the concentration of H-7 used to impinge sufficiently on PKC activity. Evidence supporting the notion that these inhibitors did not act in a non-specific manner includes the failure of either inhibitor to affect basal progesterone production. In addition, the major enzyme inhibited non-specifically by H-7 and staurosporine, A-kinase, is probably not involved in PRL action (Rillema et al. 1988) .
Pharmacological activation of PKC (PMA effect) does not exactly mimic the luteotrophic effect of PRL in this study. This suggests that PRL signalling involves more than simple activation of PKC. Recent reports on PRL, growth hormone and other members of the cytokine receptor superfamily have indicated that additional major pathways are involved in signal transduction of these ligands. These include the JAK/STAT pathway and the receptor-associated tyrosine kinase (src family)/Ras pathway (Doppler 1994 , Postel-Vinay & Finidori 1995 , Schindler 1995 , Watson & Burdon 1996 . In studies performed mostly on T-cells, PRL was found to activate JAK2 and STATs (STAT1, STAT3, STAT5) (Campbell et al. 1994 , Watson & Burdon 1996 , Rui et al. 1994 , DaSilva et al. 1996 as well as receptor-associated tyrosine kinases (Clevenger & Medaglia 1994 , Carey & Liberti 1995 . Moreover, it was demonstrated that PRL activates Raf-1 kinase (Clevenger et al. 1994 ) and mitogenactivated protein kinase (Carey & Liberti 1995) , both implicated as key intermediates that transduce the signal from upstream tyrosine kinases to downstream nuclear factors (Pelech 1993) .
Interestingly, it appears that tyrosine kinases may stimulate activity of PKC (Liu 1996 , Foster 1993 , Boudewijn et al. 1995 , Erpel & Courtneidge 1995 through phospholipases (C, D, A 2 ) and/or phosphatidylinositol 3-kinase. PKC, in turn, was demonstrated to activate Ras, Raf and mitogen-activated protein kinase as well as other enzymes and proto-oncogene products (for a review see Liu 1996) . Cross-talk between tyrosine kinase and/or the Ras pathway and PKC is being suggested in more and more reports (Rao et al. 1995 , Boudewijn et al. 1995 , Shrikant et al. 1996 . The involvement of such interpathway interaction in PRL signalling in gonadal tissue remains conjecture. Further work is needed to determine the importance of the tyrosine kinases and interpathway interactions for PRL action in the early corpus luteum of the pig.
In summary, we have demonstrated that PRL stimulates the function of the early corpora lutea of the pig by a mechanism requiring substrate for steroidogenesis and involving activation of PKC. The PKC activation does not appear to occur through the action of PI-PLC, but may be due to an unusual mechanism of PKC activation not dependent upon increases in [Ca 2+ ] i . The latter assumption, however, has to be confirmed by additional studies. The fact that pharmacological activation of PKC does not exactly mimic the effect of PRL in the porcine early corpora lutea may suggest that PRL signalling involves more than simple activation of PKC. PRL signal transduction in the forming corpus luteum probably requires activation of multiple pathways and is mediated through several enzymes including PKC. Ciereszko RE, Guan Z, Stokes BT, Petroff BK & Ottobre JS 1995 Arachidonic acid inhibits hCG-stimulated progesterone production by corpora lutea of primate: potential mechanism of action.
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